Variant report

Variant	nsv879490
Chromosome Location	chr4:74258832-74285223
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:421)
CpG islands
(count:612)
Chromatin interactive
region (count:6)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:421 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:74281297-74281307	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:74269362-74270512	HepG2	liver:	n/a	chr4:74270453-74270469
3	ARID3A	chr4:74275185-74275541	HepG2	liver:	n/a	n/a
4	ARID3A	chr4:74277177-74277971	HepG2	liver:	n/a	n/a
5	ARID3A	chr4:74262591-74263819	HepG2	liver:	n/a	n/a
6	ARID3A	chr4:74258770-74258934	K562	blood:	n/a	n/a
7	ARID3A	chr4:74271690-74272547	HepG2	liver:	n/a	n/a
8	ARID3A	chr4:74281539-74282715	HepG2	liver:	n/a	n/a
9	ARID3A	chr4:74266904-74267534	HepG2	liver:	n/a	n/a
10	ARID3A	chr4:74272842-74273336	HepG2	liver:	n/a	n/a
11	BACH1	chr4:74272494-74272496	H1-hESC	embryonic stem cell:	n/a	n/a
12	BACH1	chr4:74272407-74272542	K562	blood:	n/a	n/a
13	BHLHE40	chr4:74271712-74272073	HepG2	liver:	n/a	n/a
14	BHLHE40	chr4:74269871-74270148	HepG2	liver:	n/a	n/a
15	BRCA1	chr4:74271829-74271834	HepG2	liver:	n/a	n/a
16	CCNT2	chr4:74258662-74258953	K562	blood:	n/a	n/a
17	CEBPB	chr4:74274251-74274589	HepG2	liver:	n/a	n/a
18	CEBPB	chr4:74274350-74274501	HepG2	liver:	n/a	n/a
19	CEBPB	chr4:74281593-74281901	HepG2	liver:	n/a	chr4:74281704-74281715
20	CEBPB	chr4:74262084-74263029	HepG2	liver:	n/a	n/a
21	CEBPB	chr4:74284445-74284766	HepG2	liver:	n/a	chr4:74284600-74284613 chr4:74284602-74284613 chr4:74284524-74284537 chr4:74284600-74284613 chr4:74284602-74284613 chr4:74284600-74284611
22	CEBPB	chr4:74269746-74270021	HepG2	liver:	n/a	chr4:74269896-74269907 chr4:74269916-74269924
23	CEBPB	chr4:74281549-74281983	HepG2	liver:	n/a	chr4:74281704-74281715
24	CEBPB	chr4:74274293-74274522	H1-hESC	embryonic stem cell:	n/a	n/a
25	CEBPB	chr4:74281532-74281913	HepG2	liver:	n/a	chr4:74281704-74281715
26	CEBPB	chr4:74262755-74262882	K562	blood:	n/a	n/a
27	CEBPB	chr4:74281516-74282016	HepG2	liver:	n/a	chr4:74281704-74281715
28	CEBPB	chr4:74262833-74263000	HepG2	liver:	n/a	n/a
29	CEBPB	chr4:74272976-74273344	HepG2	liver:	n/a	n/a
30	CEBPB	chr4:74281692-74281851	K562	blood:	n/a	chr4:74281704-74281715
31	CEBPB	chr4:74271291-74271444	HepG2	liver:	n/a	chr4:74271363-74271374
32	CEBPB	chr4:74281642-74281919	H1-hESC	embryonic stem cell:	n/a	chr4:74281704-74281715
33	CEBPB	chr4:74275337-74275531	HepG2	liver:	n/a	chr4:74275438-74275451
34	CEBPB	chr4:74281664-74281800	IMR90	lung:	n/a	chr4:74281704-74281715
35	CEBPD	chr4:74281549-74281954	HepG2	liver:	n/a	n/a
36	CEBPD	chr4:74269909-74270166	HepG2	liver:	n/a	n/a
37	CEBPD	chr4:74262837-74263055	HepG2	liver:	n/a	n/a
38	CREB1	chr4:74271575-74272661	HepG2	liver:	n/a	n/a
39	CTCF	chr4:74283513-74283610	GM10266	blood:	n/a	n/a
40	E2F4	chr4:74267333-74267533	MCF10A-Er-Src	breast:	n/a	n/a
41	EP300	chr4:74281523-74281953	HepG2	liver:	n/a	n/a
42	EP300	chr4:74263134-74263727	HepG2	liver:	n/a	n/a
43	EP300	chr4:74261904-74262671	HepG2	liver:	n/a	n/a
44	EP300	chr4:74266882-74267567	HepG2	liver:	n/a	chr4:74267146-74267160 chr4:74267395-74267404 chr4:74266924-74266933
45	EP300	chr4:74281438-74282102	HepG2	liver:	n/a	n/a
46	EP300	chr4:74258715-74258999	K562	blood:	n/a	n/a
47	EP300	chr4:74263173-74263746	HepG2	liver:	n/a	n/a
48	EP300	chr4:74261971-74262367	HepG2	liver:	n/a	n/a
49	EP300	chr4:74269522-74270319	HepG2	liver:	n/a	n/a
50	EP300	chr4:74269609-74270223	HepG2	liver:	n/a	n/a

(count:612 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:74274353-74274403	NT2-D1	testis:	n/a
2	chr4:74277799-74277849	NHBE	bronchial:	n/a
3	chr4:74274353-74274403	NT2-D1	testis:	n/a
4	chr4:74277799-74277849	NHBE	bronchial:	n/a
5	chr4:74279174-74279224	A549	lung:	n/a
6	chr4:74274353-74274403	HL-60	blood:	n/a
7	chr4:74280794-74280844	NHBE	bronchial:	n/a
8	chr4:74280794-74280844	Hela-S3	cervix:	n/a
9	chr4:74274452-74274502	ProgFib	skin:	n/a
10	chr4:74269908-74269958	NHBE	bronchial:	n/a
11	chr4:74274452-74274502	NT2-D1	testis:	n/a
12	chr4:74280794-74280844	HUVEC	blood vessel:	n/a
13	chr4:74277723-74277773	GM12891	blood:	n/a
14	chr4:74279138-74279188	BE2_C	brain:	n/a
15	chr4:74280794-74280844	HNPCEpiC	eye:	n/a
16	chr4:74280794-74280844	SK-N-SH_RA	brain:	n/a
17	chr4:74269908-74269958	BE2_C	brain:	n/a
18	chr4:74274452-74274502	ovcar-3	ovarian:	n/a
19	chr4:74277723-74277773	IMR90	lung:	fetal
20	chr4:74274353-74274403	HCF	heart:	n/a
21	chr4:74280794-74280844	PFSK-1	brain:	n/a
22	chr4:74277799-74277849	Hela-S3	cervix:	n/a
23	chr4:74269908-74269958	ovcar-3	ovarian:	n/a
24	chr4:74280794-74280844	RPTEC	kidney:	n/a
25	chr4:74274353-74274403	HMEC	breast:	n/a
26	chr4:74269525-74269575	PFSK-1	brain:	n/a
27	chr4:74274452-74274502	PFSK-1	brain:	n/a
28	chr4:74274452-74274502	HEEpiC	esophagus:	n/a
29	chr4:74280794-74280844	A549	lung:	n/a
30	chr4:74269525-74269575	SK-N-SH	brain:	n/a
31	chr4:74269525-74269575	HCPEpiC	choroid plexus:	n/a
32	chr4:74279174-74279224	GM06990	blood:	n/a
33	chr4:74274353-74274403	HCPEpiC	choroid plexus:	n/a
34	chr4:74279138-74279188	CMK	blood:	n/a
35	chr4:74274353-74274403	HRE	kidney:	n/a
36	chr4:74277799-74277849	HRCEpiC	kidney:	n/a
37	chr4:74277723-74277773	HL-60	blood:	n/a
38	chr4:74269908-74269958	Hela-S3	cervix:	n/a
39	chr4:74269525-74269575	HRPEpiC	eye:	n/a
40	chr4:74274452-74274502	AG04449	skin:	fetal
41	chr4:74274353-74274403	PFSK-1	brain:	n/a
42	chr4:74269908-74269958	H1-hESC	embryonic stem cell:	embryo
43	chr4:74279174-74279224	HRPEpiC	eye:	n/a
44	chr4:74277799-74277849	BJ	skin:	n/a
45	chr4:74277723-74277773	BE2_C	brain:	n/a
46	chr4:74279174-74279224	K562	blood:	n/a
47	chr4:74269525-74269575	ovcar-3	ovarian:	n/a
48	chr4:74274353-74274403	ECC-1	luminal epithelium:	n/a
49	chr4:74269908-74269958	K562	blood:	n/a
50	chr4:74274353-74274403	HPAEpiC	pulmonary alveolar:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:74276426..74278467-chr4:74310127..74311716,2	K562	blood:
2	chr4:74256949..74258669-chr4:74264666..74267423,2	K562	blood:
3	chr4:74281238..74283827-chr4:74315947..74318394,2	K562	blood:
4	chr4:74264519..74266285-chr4:74273662..74276014,2	K562	blood:
5	chr4:74271142..74273142-chr4:74275880..74278467,2	K562	blood:
6	chr4:74122758..74124743-chr4:74269712..74272494,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AFP-1	chr4:74284998-74285172	NONHSAT096847

No data

Variant related genes	Relation type
ALB	TF binding region
ALB	CpG island
ENSG00000081051	chromatin interactions
ENSG00000163631	chromatin interactions
ENSG00000132466	chromatin interactions

Extended variants
information (count: 1017 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:1017 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs28432920	chr4:74258832-74258833	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs79303211	chr4:74258833-74258834	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs182154839	chr4:74258871-74258872	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs546315657	chr4:74258955-74258956	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs571191128	chr4:74258980-74258981	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs538376500	chr4:74258987-74258988	Flanking Active TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs28597913	chr4:74259025-74259026	Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs376336739	chr4:74259075-74259076	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs568721126	chr4:74259077-74259078	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs200983334	chr4:74259082-74259083	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs147946997	chr4:74259091-74259092	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs554320906	chr4:74259226-74259227	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs564331500	chr4:74259286-74259287	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs540485874	chr4:74259318-74259319	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs141553776	chr4:74259345-74259346	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs577919903	chr4:74259360-74259361	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs545525746	chr4:74259380-74259381	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs563811724	chr4:74259388-74259389	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs531025888	chr4:74259403-74259404	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs543273736	chr4:74259416-74259417	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs535111606	chr4:74259431-74259432	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs186916651	chr4:74259487-74259488	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs150390276	chr4:74259493-74259494	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs530496619	chr4:74259565-74259566	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs562447563	chr4:74259607-74259608	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs576081060	chr4:74259610-74259611	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs547243763	chr4:74259649-74259650	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs564730509	chr4:74259726-74259727	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs532092131	chr4:74259732-74259733	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs116661054	chr4:74259746-74259747	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs191763543	chr4:74259776-74259777	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs535926536	chr4:74259964-74259965	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs565658163	chr4:74259982-74259983	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs547997331	chr4:74260008-74260009	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs566631962	chr4:74260026-74260027	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs533846009	chr4:74260115-74260116	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs558773752	chr4:74260166-74260167	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs138144615	chr4:74260205-74260206	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs182626049	chr4:74260207-74260208	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs557412432	chr4:74260232-74260233	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs531653019	chr4:74260258-74260259	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs575844411	chr4:74260279-74260280	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs187053553	chr4:74260338-74260339	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs561347789	chr4:74260355-74260356	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs34686165	chr4:74260402-74260403	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs527992064	chr4:74260403-74260404	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs565612769	chr4:74260410-74260411	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs573833481	chr4:74260415-74260416	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs547672227	chr4:74260426-74260427	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs190338472	chr4:74260483-74260484	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Myelofibrosis	22110671	CNVD
Abnormal phenotypes	18644119	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Cancer	22429812	CNVD
Intracranial aneurysm	16715129	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21720365	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21240255	CNVD

Chromatin state (count:55 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:74256400-74260200	Enhancers	HepG2	liver
2	chr4:74258000-74259000	Flanking Active TSS	Liver	Liver
3	chr4:74259000-74262600	Enhancers	Liver	Liver
4	chr4:74260200-74260600	Weak transcription	HepG2	liver
5	chr4:74260600-74263000	Enhancers	HepG2	liver
6	chr4:74262600-74264600	Flanking Active TSS	Liver	Liver
7	chr4:74263000-74263400	Flanking Active TSS	HepG2	liver
8	chr4:74263400-74264400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
9	chr4:74263400-74266800	Enhancers	HepG2	liver
10	chr4:74264600-74266000	Enhancers	Liver	Liver
11	chr4:74266000-74266400	Flanking Active TSS	Liver	Liver
12	chr4:74266400-74269200	Enhancers	Liver	Liver
13	chr4:74266800-74267000	Enhancers	Pancreas	Pancrea
14	chr4:74266800-74267000	Flanking Active TSS	HepG2	liver
15	chr4:74266800-74267400	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr4:74267000-74267200	Enhancers	HepG2	liver
17	chr4:74267000-74271400	Weak transcription	Pancreas	Pancrea
18	chr4:74267200-74267400	Flanking Active TSS	HepG2	liver
19	chr4:74267400-74269400	Enhancers	HepG2	liver
20	chr4:74269200-74269800	Flanking Active TSS	Liver	Liver
21	chr4:74269400-74269600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
22	chr4:74269400-74270000	Flanking Active TSS	HepG2	liver
23	chr4:74269800-74272000	Active TSS	Liver	Liver
24	chr4:74270000-74271200	Active TSS	Pancreatic Islets	Pancreatic Islet
25	chr4:74270000-74271600	Active TSS	HepG2	liver
26	chr4:74271400-74272000	Active TSS	Pancreas	Pancrea
27	chr4:74271600-74283200	Transcr. at gene 5' and 3'	HepG2	liver
28	chr4:74272000-74283400	Transcr. at gene 5' and 3'	Liver	Liver
29	chr4:74272000-74298200	Weak transcription	Pancreas	Pancrea
30	chr4:74272200-74273600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr4:74273800-74274400	Enhancers	Fetal Intestine Large	intestine
32	chr4:74274000-74274400	Enhancers	ES-I3 Cell Line	embryonic stem cell
33	chr4:74274000-74274400	Enhancers	iPS-15b Cell Line	embryonic stem cell
34	chr4:74274000-74274600	Enhancers	HUES48 Cell Line	embryonic stem cell
35	chr4:74274000-74275200	Enhancers	iPS-18 Cell Line	embryonic stem cell
36	chr4:74274000-74276000	Enhancers	Fetal Intestine Small	intestine
37	chr4:74274200-74274600	Enhancers	iPS-20b Cell Line	embryonic stem cell
38	chr4:74274200-74274600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr4:74274200-74275400	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr4:74274400-74275600	Weak transcription	Fetal Intestine Large	intestine
41	chr4:74274600-74275200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
42	chr4:74275200-74275400	Enhancers	iPS-20b Cell Line	embryonic stem cell
43	chr4:74275600-74276200	Enhancers	Fetal Intestine Large	intestine
44	chr4:74280400-74286400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
45	chr4:74281600-74282000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr4:74283200-74283600	Active TSS	HepG2	liver
47	chr4:74283400-74287400	Strong transcription	Liver	Liver
48	chr4:74283600-74284200	Transcr. at gene 5' and 3'	HepG2	liver
49	chr4:74284200-74284400	Genic enhancers	HepG2	liver
50	chr4:74284400-74287000	Strong transcription	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links